Royalty Pharma: Post Q3 Earnings, We Reiterated Our Strong Buy (NASDAQ:RPRX)
By Press Room
3 Mins read
In September end, we decided to initiate coverage of Royalty Pharma plc (NASDAQ:RPRX), and today, the company released its quarterly figures. Solid…
By Breakingviews For Compagnie Financiere Richemont, not all that glitters is gold. The $65 billion owner of jeweler Cartier finally agreed to…
Moody’s changed the outlook to negative On Friday after the market closed, Moody’s changed the outlook on US Government debt to negative…
Bioventus Inc. (NASDAQ:BVS) Q3 2023 Earnings Conference Call November 7, 2023 8:30 AM ET Company Participants Dave Crawford – Vice President, Investor…
Introduction As a dividend growth investor, I seek new investment opportunities in income-producing assets. I often add to my existing positions when…
It’s the same old song. Mega-cap tech stocks continue to power the S&P 500 and broad US stock market higher in 2023….
iHeartMedia (NASDAQ:IHRT) emerged from bankruptcy in July 2019. Since then, IHRT has proved a very disappointing investment as shares have delivered a…
Snap One Holdings Corp. (NASDAQ:SNPO) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Eric Steele – Senior…
My regular readers know I have put out a slew of negative to bearish takes since summertime on the leading Big Tech…
MDxHealth SA (OTC:MXDHF) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Michael McGarrity – Chief Executive Officer…